| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Clinical Chemistry, Vol 37, 845-852, Copyright © 1991 by American Association for Clinical Chemistry
J Mair, E Artner-Dworzak, P Lechleitner, J Smidt, I Wagner, F Dienstl and B Puschendorf
Department of Medical Chemistry and Biochemistry, University of Innsbruck, Austria.
Troponin T is a structurally bound protein found in striated muscle cells. We tested concentrations of its cardiac-specific isotype in peripheral venous blood samples serially drawn from 72 patients with confirmed myocardial infarction. Fifty-nine patients received thrombolytic treatment with intravenous streptokinase, urokinase, or recombinant tissue-type plasminogen activator; because of contraindications, the remaining 13 patients did not. Concentrations of troponin T in plasma, measured by an enzyme-linked immunosorbent assay, started increasing within a few hours after the onset of symptoms (median, 4 h; range, 1-10 h). The sensitivity of troponin T for detecting myocardial infarction was 100% from 10 to 120 h after the onset of symptoms; sensitivity on the seventh day after admission was 84%. Concentrations were increased for up to three weeks in some patients with late or high peak values. Successful reperfusion in Q- wave infarction obviously influences the release of troponin T into plasma, with all such cases showing peak values less than or equal to 26 h (median, 14 h) after the onset of symptoms. Troponin T concentrations in these patients returned to within the reference interval more rapidly than in nonreperfused subjects. In the 13 patients without fibrinolytic therapy, troponin T tended to peak approximately 48 h (median) after the onset of chest pain. Troponin T concentrations in patients for whom thrombolysis was unsuccessful resembled those in patients without fibrinolytic therapy. The specificity of the assay was 96% as tested in samples of 96 emergency- room patients. The reference interval (less than 0.5 micrograms/L) was established from samples of 100 healthy blood donors. Troponin T measurements are a specific and sensitive method for the early and late diagnosis of acute myocardial infarction and could, therefore, provide a new criterion in laboratory diagnosis of its occurrence.
The following articles in journals at HighWire Press have cited this article:
|
|
 |
|
  S. Kilickap, I. Barista, E. Akgul, K. Aytemir, S. Aksoyek, S. Aksoy, I. Celik, S. Kes, and G. Tekuzman cTnT can be a useful marker for early detection of anthracycline cardiotoxicity Ann. Onc., May 1, 2005; 16(5): 798 - 804. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Rej Clinical Chemistry through Clinical Chemistry: A Journal Timeline Clin. Chem., December 1, 2004; 50(12): 2415 - 2458. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. L. Nagy, M. Collins, T. Sharpe, S. Mirsadraee, R. R. Guerrero, J. Gibbs, and K. G. Watterson Effect of Two Different Bypass Techniques on the Serum Troponin-T Levels in Newborns and Children: Does pH-Stat Provide Better Protection? Circulation, August 5, 2003; 108(5): 577 - 582. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. T. Sandri, D. Cardinale, L. Zorzino, R. Passerini, P. Lentati, A. Martinoni, G. Martinelli, and C. M. Cipolla Minor Increases in Plasma Troponin I Predict Decreased Left Ventricular Ejection Fraction after High-Dose Chemotherapy Clin. Chem., February 1, 2003; 49(2): 248 - 252. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. J. Fransen, J. H. C. Diris, J. G. Maessen, W. Th. Hermens, and M. P. van Dieijen-Visser Evaluation of "New" Cardiac Markers for Ruling Out Myocardial Infarction After Coronary Artery Bypass Grafting Chest, October 1, 2002; 122(4): 1316 - 1321. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Peetz, G. Hafner, and K. J. Lackner Analytical Characteristics of the AxSYM Cardiac Troponin I and Creatine Kinase MB Assays Clin. Chem., July 1, 2002; 48(7): 1110 - 1111. [Full Text] [PDF]
|
|
|
|
 |
|
 K R Herren, K Mackway-Jones, C R Richards, C J Seneviratne, M W France, and L Cotter Is it possible to exclude a diagnosis of myocardial damage within six hours of admission to an emergency department? Diagnostic cohort study BMJ, August 18, 2001; 323(7309): 372 - 372. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. S. Ooi, P. A. Isotalo, and J. P. Veinot Correlation of Antemortem Serum Creatine Kinase, Creatine Kinase-MB, Troponin I, and Troponin T with Cardiac Pathology Clin. Chem., March 1, 2000; 46(3): 338 - 344. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. B Sacks Acute coronary ischemia: troponin I and T Vascular Medicine, November 1, 1999; 4(4): 253 - 256. [Abstract] [PDF]
|
|
|
|
 |
|
 R. Rehmani and S. Amanullah Analysis of blood tests in the emergency department of a tertiary care hospital Postgrad. Med. J., November 1, 1999; 75(889): 662 - 666. [Abstract] [Full Text]
|
|
|
|
 |
|
 T. M. Hurst, M. Hinrichs, C. Breidenbach, N. Katz, and B. Waldecker Detection of myocardial injury during transvenous implantation of automatic cardioverter-defibrillators J. Am. Coll. Cardiol., August 1, 1999; 34(2): 402 - 408. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. H. Herman, J. Zhang, S. E. Lipshultz, N. Rifai, D. Chadwick, K. Takeda, Z.-X. Yu, and V. J. Ferrans Correlation Between Serum Levels of Cardiac Troponin-T and the Severity of the Chronic Cardiomyopathy Induced by Doxorubicin J. Clin. Oncol., July 1, 1999; 17(7): 2237 - 2237. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Coudrey The Troponins Arch Intern Med, June 8, 1998; 158(11): 1173 - 1180. [Full Text] [PDF]
|
|
|
|
|
|
P. J. O'Brien, Y. Landt, and J. H. Ladenson Differential reactivity of cardiac and skeletal muscle from various species in a cardiac troponin I immunoassay Clin. Chem., December 1, 1997; 43(12): 2333 - 2338. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S. Luscher, K. Thygesen, J. Ravkilde, and L. Heickendorff Applicability of Cardiac Troponin T and I for Early Risk Stratification in Unstable Coronary Artery Disease Circulation, October 21, 1997; 96(8): 2578 - 2585. [Abstract] [Full Text]
|
|
|
|
|
|
V. Ricchiuti, J. Zhang, and F. S. Apple Cardiac troponin I and T alterations in hearts with severe left ventricular remodeling Clin. Chem., June 1, 1997; 43(6): 990 - 995. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. S. Bodor, L. Survant, E. M. Voss, S. Smith, D. Porterfield, and F. S. Apple Cardiac troponin T composition in normal and regenerating human skeletal muscle Clin. Chem., March 1, 1997; 43(3): 476 - 484. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. M. Ohman, P. W. Armstrong, R. H. Christenson, C. B. Granger, H. A. Katus, C. W. Hamm, M. A. O'Hanesian, G. S. Wagner, N. S. Kleiman, F. E. Harrell, et al. Cardiac Troponin T Levels for Risk Stratification in Acute Myocardial Ischemia N. Engl. J. Med., October 31, 1996; 335(18): 1333 - 1342. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Brackenbury, R. Sherwood, N. Meehan, M. Whitehorne, A. Forsyth, M. Marrinan, and J. Desai Troponin T release with warm and cold cardioplegia Perfusion, September 1, 1996; 11(5): 377 - 382. [Abstract] [PDF]
|
|
|
|
|
|
R. J. de Winter, R. W. Koster, A. Sturk, and G. T. Sanders Value of Myoglobin, Troponin T, and CK-MBmass in Ruling Out an Acute Myocardial Infarction in the Emergency Room Circulation, December 15, 1995; 92(12): 3401 - 3407. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. Lofberg, R. Tahtela, M. Harkonen, and H. Somer Myosin Heavy-Chain Fragments and Cardiac Troponins in the Serum in Rhabdomyolysis: Diagnostic Specificity of New Biochemical Markers Arch Neurol, December 1, 1995; 52(12): 1210 - 1214. [Abstract] [PDF]
|
|
|
|
|
|
M. Muller-Bardorff, H. Freitag, T. Scheffold, A. Remppis, W. Kubler, and H. A. Katus Development and Characterization of a Rapid Assay for Bedside Determinations of Cardiac Troponin T Circulation, November 15, 1995; 92(10): 2869 - 2875. [Abstract] [Full Text]
|
|
|
|
 |
|
 E. M. Antman, C. Grudzien, and D. B. Sacks Evaluation of a Rapid Bedside Assay for Detection of Serum Cardiac Troponin T JAMA, April 26, 1995; 273(16): 1279 - 1282. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
